Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study
一种改良型mRNA-脂质纳米颗粒候选疫苗对COVID-19的安全性和免疫原性：一项1期剂量递增研究的结果
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2024.2408863
Essink, Brandon J; Shapiro, Craig; Isidro, Marie Grace Dawn; Bradley, Paul; Pragalos, Antoinette; Bloch, Mark; Santiaguel, Joel; Frias, Melchor Victor; Miyakis, Spiros; Alves de Mesquita, Margarida; Berrè, Stefano; Servais, Charlotte; Waugh, Natasha; Hoffmann, Claudia; Baba, Emna; Schönborn-Kellenberger, Oliver; Wolz, Olaf-Oliver; Koch, Sven D; Ganyani, Tapiwa; Boutet, Philippe; Mann, Philipp; Mueller, Stefan O; Ramanathan, Roshan; Gaudinski, Martin Robert; Vanhoutte, Nicolas
